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Abstract: The objective of this paper is to document the knowledge and experiences of healthcare 
professionals and researchers in Australia about the barriers to controlling Strongyloides 
stercoralis in Australian Indigenous communities. Qualitative research methods were used 
to conduct in-depth semi-structured interviews, which were digitally recorded, transcribed, 
and participant-checked. Data were thematically analysed to identify significant themes. Five 
major themes were identified:
1. Barriers to health/treatment;
2. Access to healthcare;
3. Policy;
4. Learning opportunity; and
5. Ideas for intervention.
The findings suggest that Australian Indigenous communities will continue to suffer increased 
morbidity and mortality due to a lack of control or prevention of Strongyloides stercoralis. Issues 
such as institutional racism, improvements to health promotion, education, socioeconomic 
determinants, and health care system policy and procedures need to be addressed. This study 
identifies several direct implications for Indigenous health:
• The need for increased knowledge and understanding of the risks to health for Indigenous
community members;
• The need for prevention policy development for neglected tropical diseases in Indigenous
communities;
• The need for increased knowledge and understanding of the treatment, diagnosis, and
healthcare access concerning Strongyloides stercoralis for health professionals and
policymakers who work within Indigenous health;
• The need to raise awareness of systematic institutional racism in the control and prevention 
of neglected tropical diseases in Indigenous communities; and
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• The need for a health promotion framework that can provide the basis for multiple-level 
interventions to control and prevent Strongyloides in Indigenous communities.
Introduction
Infectious diseases contribute significantly to the morbidity and mortality of Indigenous 
Australians, particularly in rural and remote communities, at a much higher rate than in 
the mainstream Australian community (AIHW 2015; Holt, McCarthy and Carapetis 2010; 
Flannery and White 1993). There are many highly effective interventions for the control of 
these diseases. However, implementation of these interventions in rural Indigenous com-
munities is frequently suboptimal. Barriers at multiple levels appear to impact on effective 
interventions in Indigenous communities. 
Strongyloides stercoralis is an intestinal nematode transmitted by contact with damp soil 
containing infective larvae (Speare 1989; Sheory, Walker and Biggs 2000). These infective 
larvae are developed from faeces indiscriminately deposited on the ground. The larvae 
penetrate the skin and travel to the lungs, where they penetrate the alveolar spaces and 
are carried through the bronchial tree to the pharynx (Sheory, Walker and Biggs 2000). 
They are then swallowed and reach the intestines where they develop into adults that live 
in tunnels in the small intestinal mucosa (Sheory, Walker and Biggs 2000). The uniqueness 
of S. stercoralis is that it can become autoinfectious, with small infective larvae formed 
in the gut and re-entering the tissues by penetrating the wall of the lower bowel. The 
practical result of this is that a single infection can last many years and probably for life; the 
longest recorded infection is 65 years (Leighton and MacSween 1990). Also, if the immune 
response of the host is suppressed, the rate of successful colonisation by autoinfective larvae 
increases, the number of adult worms in the gut rises, and a serious and potentially fatal 
disease (the hyperinfective syndrome) develops. 
The significance of strongyloidiasis in rural and remote Indigenous communities is that 
it is a highly infectious parasite, a disease with a unique life-cycle of autoinfection that 
causes a variety of symptoms, including fatality from hyper-infection and lifelong infection 
if left untreated (Johnson et al. 2005). Australian Indigenous people living in rural and 
remote settings are exposed to and are infected with S. stercoralis. Some of the highest 
prevalence levels in the world have been recorded in northern Australia, with a prevalence 
of 40% not uncommon in some groups (Adams, Page and Speare 2003). In most societies, 
the prevalence is under 5%, even in communities with severe poverty. The impact of the 
parasite on communities has been documented, including case reports of serious disease 
(Walker, Blake and Downing 1976; Yiannakou et al. 1992; Mak 1993). One case series 
(Kukuruzovic et al. 2002) showed that Indigenous children with acute strongyloidiasis and 
diarrhoea were more likely to have hypokalaemia (low blood potassium) than were similar 
children with diarrhoea due to other causes. Work has been done in remote Australian 
Indigenous communities with mass drug administration (MDA) programs such as those 
conducted by Kearns et al. (2009) administering ivermectin across communities to attempt 
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an eradication of scabies and strongyloidiasis. Recently, Kearns et al. (2017) focused on 
administering ivermectin for the treatment of strongyloidiasis across two remote Australian 
Indigenous communities. Both studies have presented research supporting that MDA 
programs incorporating routine treatment with community engagement and education can 
decrease and potentially eradicate strongyloidiasis (Kearns et al. 2009; Kearns et al. 2017). 
FIGURE 1. The life cycle of Strongyloides stercoralis  (CDC 2015)   
Diagnostic tests suitable for use in Australian Indigenous communities are available. 
Speare and Durrheim (2004) estimated that detecting and curing a positive case of 
strongyloidiasis in these hyperendemic northern communities are relatively inexpensive, 
costing $590 per case if community-wide screening were implemented. In Caucasian 
groups, chronic strongyloidiasis produces significant symptomatology in 67% of infected 
individuals (Grove 1980). There is no reason to believe this is not the case in Indigenous 
Australians. The diagnosis of strongyloidiasis in mainstream Australians with no risk 
factors, particularly related to travel history, is so rare that there are few to no published 
case reports. 
A systematic review of the peer-reviewed literature published between 1969 and 2010 
has presented the status of strongyloidiasis for Australian Indigenous community members 
and summarized the barriers to its control (Miller et al. 2014). The main barriers to 
management are health status, socioeconomic status, healthcare literacy, and procedures. 
Concurrent health conditions and infections, living conditions and racial disparities, the 
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difficulty of detection, and inadequate knowledge/treatment (e.g., medication dosage) are, 
but a few of the main barriers presented (Miller et al. 2014). 
The barriers to controlling infectious diseases for health improvement at the personal 
level in rural and remote Indigenous communities include
1. communication difficulties between health staff and Indigenous patients based on 
the lack of a shared understanding of disease causation and the simple fact that 
English is not the first language for many people in remote locations (Trudgeon 
2000; McConnel 2003; Cheng, Blum and Spain 2004);
2. fear of disclosure of culturally sensitive illnesses (Newman et al. 2007)
3. fear of discrimination (Lowe et al. 1995; Trudgeon 2000; Newman et al. 2007);
4. remoteness from essential specialised health services (Gruen, Weeramanthri and 
Bailie 2002; McGrath 2006);
5. lack of the funds needed to purchase medication and equipment (Couzos and Davis 
2005; Couzos 2005);
6. the need for education in maternal and child health (Molyneux 2006);
7. the need for involvement from other government sectors and agencies (Molyneux 
2006);
8. the need for the establishment of surveillance, diagnosis, monitoring, and evaluation 
systems (Molyneux 2006); and
9. at the population and governmental levels, the potential influence of racist attitudes 
negatively impacting health expectations and services (Lowe, Kerridge and Mitchell 
1995; Trudgeon 2000; Aldrich, Zwi and Short 2007).
Although many barriers have been explored from the intervention perspective, 
no research has qualitatively explored the barriers from the Indigenous community’s 
perspective—the health service staff working in Indigenous communities—or have 
documented the experiences of leading experts in the field outside of their clinical 
intervention or professional role.
Strongyloidiasis is not considered a notifiable disease in the Australian public health 
system (Speare, Miller and Page 2015). The purpose of this study is to describe the barriers 
for the prevention, treatment, and control S. stercoralis from the perspective of experienced 
researchers and healthcare workers in Australia. S. stercoralis infects humans mainly through 
skin contact with contaminated soil. In discussing the control of communicable diseases such 
as strongyloidiasis, the term “control” implies prevention. In this study, the authors want to 
make it explicit that prevention must be considered from a public health and Indigenous 
community perspective. The perspectives of researchers and community members affected 
by S. stercoralis or other infectious diseases have a better chance of influencing policy. Policy 
development about control and prevention must deal with and address institutional racism 
for successful implementation (including the key messages to government, researchers, and 
community members). For the purposes of this paper, the authors focus on these policy 
implications and therefore do not specifically explore the eradication of S. stercoralis. 
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In a systematic review of the barriers to the control of strongyloidiasis, Miller et al. 
(2014) described the need for a detailed, clinical picture in order to manage S. stercoralis 
in Australia, including prevalence rates, evidence, and community-based public health 
approaches to control strongyloidiasis. This study explores the barriers to the implementation 
of infectious disease interventions for diagnosing, treating, and preventing strongyloidiasis 
from the perspective of experienced healthcare professionals with extensive medical 
knowledge and experience in the field of researching and/or diagnosing and treating 
strongyloidiasis. The aim of this paper is to document the knowledge and experiences 
of these experienced healthcare professionals concerning strongyloidiasis in Indigenous 
Australian communities and to use their knowledge and experience to better understand 
the policy implications for controlling and preventing strongyloidiasis.
Methods
The study was conducted in Australia and focused on barriers to the treatment, control, and 
prevention of strongyloidiasis in Indigenous communities. The authors used a descriptive 
qualitative study to explore the perspectives of healthcare professionals as key informants 
for strongyloidiasis in the context of Indigenous communities, environmental health, and 
health care systems (Pope and Mays 2006; Pope, Reibland and Mays 2006). Purposive sam-
pling was used to recruit health professionals and researchers with long-term experience 
with S. stercoralis participants. The participants in this study are described as health pro-
fessionals who work within laboratories, research institutions, and primary health care ser-
vices in rural and remote and urban settings from around Australia. Participants were eligi-
ble to be included in the study if they worked in Indigenous communities in Australia and/
or had experience diagnosing and treating strongyloidiasis. Participant recruitment was 
undertaken by selecting nationally known health professionals and researchers working on 
the diagnosis and treatment of strongyloidiasis. 
Telephone interviews were conducted with participants based on a semi-structured 
interview guide. Participants were provided with open-ended interview questions prior to 
scheduled telephone interviews. These open-ended questions focused on their experiences 
with the barriers to controlling S. stercoralis, including health care system/policy, drug 
treatment, the Australian public policy context, and the Indigenous community context. 
Probes were used to help participants elaborate on their experiences in the field. All 
interviews were audio recorded and transcribed verbatim. Participants were provided 
with a copy of their transcript to confirm and approve the accuracy of the transcription. 
No revisions were requested by any of the participants. Thematic analysis using constant 
comparison was applied to the transcribed interviews (Creswell 2012). Two members of 
the research team individually coded each transcription, and then the larger research team 
met to discuss the codes and develop the coding framework.
Research ethics approval was granted by the Human Research Ethics Committee of Griffith 
University, Brisbane, Australia. All participants signed an informed consent to participate in 
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their interview and to allow information and possible quotes to be published. Their anonymity 
and confidentiality were included in the consent process. However, some participants were 
not concerned about being recognized through the information they shared. 
Results
This study identified five major themes and sub-themes as major barriers to controlling 
strongyloidiasis in Indigenous Australian communities: barriers to health/treatment, access 
to health care, policy, learning opportunities, and ideas for intervention (see Table 1).
TABLE 1: Themes and sub-themes
Major Theme Sub-theme
1. Barriers to Health/Treatment







1. 3 Community in Context
• Trust
• Environment


















Racism is perceived at both individual and institutional levels, particularly in controls over 
accessing data and knowledge of the disease.  
Infrastructure/Environment
The environment itself exposes a community to S. stercoralis infestation, an environment 
related to housing and infrastructure resulting from influences of racism that impede peo-
ple from decreasing their exposure:
Some issues in the housing, in internal housing areas, but also the external housing 
area, in particular like compromised infrastructure, like overflow in septic tanks, 
leaking taps … hardware. So we had a look at some behaviours, the activities of 
daily living in some of the houses, and where these wet areas or damp areas were 
persisting, and in particular the kids, basically, the external housing environments 
harboured the nematode. 
Participant 1
Diagnosis/Treatment
A lack of education and knowledge among health professionals about S. stercoralis, includ-
ing on infection rates, symptoms, and asymptomatic behaviour, can lead to misdiagnosis 
and ineffective treatment. The individual and institutional level of control of this necessary 
information perpetuates the issues described by health professionals in the field working 
with S. stercoralis infections:
Lot of challenges around diagnosis but diagnosis is important because if you get to 
a point where you fixed up the sanitation, and you’ve done your treatments, or all 
you do is a selective treatment program, or people come in, there are issues with 
diagnosis…the first issue of diagnosis is lack of education amongst clinicians that 
Strongyloides is a significant
Participant 4
……………………………
People have got multiple parasites, wouldn’t it be good to treat them with ivermectin 
and do some follow-up?  I don’t get it; I honestly don’t get why they only look at 
bloody treating bits and pieces and not looking at the whole raft of issues.
Participant 1
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The only way people can actually get the medication is if they’ve had a blood test 
and it comes up positive so you’re actually getting the appropriate drugs, and for 
adults it’s relatively simple because they’d normally be taking blood anyway to check 
out for chronic diseases, and then they send it off for Strongyloides as well, but for 
children they hardly ever take blood from children unless they think it’s absolutely, 
absolutely essential, so they never get tested and so they never get treated. 
Participant 2
Normalisation
The assumption that people in the community are always ill and allowing it to continue as 
a “normal state” is a form of racism, as is the perspective among the people themselves that 
feeling ill is normal for everyone:
The process, it’s called normalisation, so not feeling well becomes normal in the 
person’s mind, and so if you’re not unwell for a long period of time and somebody 
says how are you today, and you’ll say I’m okay because you haven’t been more sick, 
I suppose recently. They don’t actually recognise that they’ve got the symptoms. 
They think it’s normal to have diarrhoea all the time and belly aches and things like 
that…that process is normalisation.
Participant 2
………………………………
The terrible quotes that were around, it’s only the sick who die. I’ve just found 
strange comments coming from medical profession and then a concept you could 
treat individuals, but somehow you couldn’t treat the individuals in an endemic 
area just because it was endemic.
Participant 9
…………………………………
There is a degree where even people who are very, very good people just see so much 
morbidity all the time that from that you just get habituated to seeing it. You become 
immune to it which is not, I don’t think it’s necessarily racism, it’s not an acceptance 
that it’s right, but it’s just so often that you see these things…certainly you can get 
habituated to seeing people coming in with disastrous health problems and I think 
some people they just lose sight of the fact…I believe in the principle just because it’s a 
remote Indigenous community, health care should basically be as good as somebody 
who lives in the city essentially, and except for distance and things like that, there’s 
no reason you shouldn’t aim for the same baseline. Poor sanitation is not acceptable 




Normalisation with regards to the disease actually comes from speaking to health 
care workers, community workers, people, other researchers who have actually 
gone into the communities to look at the issue as well…I think it’s a growing issue.  
Participant 7
Diagnosis/Clinical Knowledge
S. stercoralis infection is diagnosed via blood or stool sample, and both have diagnosis lim-
itations/issues. Without diagnosis and subsequent treatment, the infection can lead to a 
suppressed immune system, life-threatening complications, and death.
Diagnosis
 Stool testing is not ideal, as larvae are intermittent and are less likely to be observed in stool 
in chronic strongyloidiasis: 
The fact that you can have chronic strongyloidiasis and you can treat it, but your 
subsequent source specimens will be negative and then like maybe seven weeks 
later one will turn up positive again. That’s just the nature of the worm, that’s just 
the nature of the beast. And the limitations with regard to finding the organism 
in the stool which requires live larvae to be present. There are issues in terms of 
specimen transportation with regard to that in Australia. 
Participant 4
……………………………
Currently, the gold standard is faecal culture, and faecal culture has a lot of practical 
issues. We rely on fresh stool samples to have an effective specimen for culture.  By 
the time a faecal sample, if submitted, reaches the lab it can be three or four days 
old and by that time the parasite’s dead so we can’t get culture, a positive culture, so 
it does concern me that we’re issuing reports saying that the culture is negative and 
giving false negative reports…that’s a practical issue. 
Participant 5
Obtaining samples is often impeded by non-compliance. For example, non-compliance 
associated with obtaining blood from children or stool samples are barriers to diagnosis 
and treatment: 
They’re much more willing to give stool samples from little children than from 
older children. I think there’s also the shame aspect of things too as well, but yeah it 
is harder to get stool samples.
Participant 2
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Strongyloides infection can be either symptomatic or asymptomatic. The longer a person 
suffers from infection, the higher the risk of hyperinfection potentially leading to death: 
Every test has its limitations, and part of the thing about clinician education is not 
just to be aware of strongyloidiasis but to be wary when all your tests are negative as 
well.  Because they can be negative, but someone might still have strongyloidiasis. 
They probably won’t on the basis of probabilities, but it comes down to a situation 
like hyperinfection, you can’t be too careful. 
Participant 4
……………………………
Under a microscope, you’ve got the situation of being able to diagnose it, but because 
it’s in chronic strongyloidiasis, it’s not necessarily showing in the faeces. It seems 
that phases you can diagnose it in the faeces are in the acute phase when someone’s 
probably got diarrhoea, and it is their first episode or certainly when disseminated. 
When [larvae] is in its millions and in both those cases, the Strongyloides in 
serology is not as reliable. The body might not have developed its own immune 
response, and in disseminated strongyloidiasis, the immune system may be so low 
that it can’t mount an immune response…in the primary care setting, we’re really 
looking for identifying those that have chronic strongyloidiasis and then looking to 
treat that before they’re actually running into the complications…people die from 
septicaemia. If you get to the disseminated phase which is when [larvae] multiplies 
into its millions having a drug that’s going to kill something that’s in its millions is 
very hard, and that’s why disseminated strongyloidiasis has a high fatality rate. 
Participant 9
Clinical Knowledge
The lack of clinical understanding of S. stercoralis leads to inadequate clinical practice, re-
duced health, and increased risk for people exposed. Health professionals armed with de-
tailed information on S. Stercoralis, prevalence, diagnosis, and treatment would radically 
influence the infection rates amongst individuals and decrease the symptoms and concur-
rent health problems resulting from strongyloidiasis: 
From a clinical perspective, I think working with the remote clinics, most of them 
don’t know about Strongyloides, they wouldn’t have a clue about it.
Participant 1
From the point of view of the clinician, I think probably an awareness of ivermectin 
and its role in eradicating Strongyloides.
Participant 6
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Strongyloides can be symptomatic, asymptomatic, or both; it can mimic many other 
illnesses. If health professionals were more aware of this issue, they could have increased 
opportunities to make accurate diagnoses:
The fact that we don’t really know how many of the ordinary everyday symptoms of 
ill health are caused by Strongyloides being inside the body as against other factors. 
And because some of the symptoms of Strongyloides infection can be nausea, 
vomiting, diarrhoea, rashes, not sleeping well, not eating well, all of those sort of 
common run of the mill symptoms of feeling crook, and we don’t go that extra step 
of testing to see whether they’ve got Strongyloides or not but it could well be that in 
many instances that’s the cause of the problem. 
Participant 6
Failure to understand the complexity of the auto-infective cycle and incorrect diagnoses can 
lead to disseminated strongyloidiasis and to extreme decreased health, and potentially death:
You’ve got a health profession that are trained in Australia that are ignorant of 
Strongyloides, It’s understanding about the auto-infective cycle and the fact that if 
you don’t think of it, you’re not going to diagnose it and the evidence is that those 
who die from strongyloidiasis, there’s probably been warnings signs beforehand, 
but medical professionals have not been alert or aware of it to consider it, and my 
experience has been that when people do die they’re actually preventable deaths.
Participant 9
Community in Context
Disease and infection can be described in the context of community. Lack of knowledge 
of the disease (including exposure and transmission processes), community experience 
with health professionals, and the community’s environment and location all influence how 




Barriers within the community can include mistrust of the health professionals:
The sort of barriers that [non-community member(s)] encountered was a lot 
of mistrust, why are they taking my blood, are they going to take it and sell it to 
someone else and make a profit out of it, those sorts of thoughts…And there were 
some people who refused to cooperate and so they just moved onto another person. 
Participant 5
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Environment
A community’s environmental health (or lack thereof) influences exposure and infection 
rates. Transmission rates increase along with reductions in environmental health: 
Environmental health [government department] can say look you’ve got a problem; 
we’re going to advocate, that sewerage system’s broken down, go and get it fixed. 
The environmental health don’t actually fix it, they have advocacy role to see that 
it’s done and then you have the infrastructure that’s managed by councils, managed 
by housing authorities, it’s managed in a different section but they usually have 
responsibility for building appropriate housing.
Participant 9
Community awareness of ways to prevent transmission could decrease the exposure and 
transmission of S. Stercoralis:
It’s actually poor sanitation, whether that’s educational to some degree with the kids 
avoiding, say if the septic tank is broken avoid running around the outflow from 
the septic tank or whether it’s just the infrastructure side of things and the good 
disposal of sewerage. 
Participant 4
Diagnosing at the community level is challenging:
They say you need three stool samples, either consecutively or three stool samples 
over a week because the Strongyloides larva output is so irregular. And certainly, 
we only ever did it by a single sample. For us in community, it is quite difficult to 
get that one sample, let alone trying to get three…to get to the laboratory from a 
community, we’re never going to see Strongyloides. What we have found is most 
of the kids have often got….bugs in their tummy. Then they’re actually treated 
for Giardia when it actual fact it could have been the Strongyloides underlying it. 
We will never know. So they would have got the three-dose of albendazole in the 
community as a sort of protocol. By the time they get the poo sample back, I think 




The inability to treat Strongyloides effectively and the difficulty of accessing health care in-
fluence the community’s ability to prevent and treat it. By engaging a full-faceted approach 
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to prevention, a program should focus on improving the environment to decrease exposure 
to and infection of S. Stercoralis: 
We concentrate on engaging those people in the house in regards to the cleanliness 
of the house, internal environment, but also the hygiene factor in the house
Participant 1
The difficulty of diagnosing Strongyloides contributed to a lack of treatment: 
The other problem with ivermectin is basically the protocols…that unless the 
person has got a positive diagnosis for Strongyloides, they’re not given ivermectin. 
If they’re suspected of having it, but they haven’t got a positive diagnosis, they will 
give albendazole, and they’ll offer three doses, but they usually only watch one of 
them being swallowed, and we know that even three doses of albendazole on three 
different days isn’t effective.
Participant 2
Disseminated Strongyloides leading to hyperinfection requires long-term treatment: 
Go by the evidence ivermectin is superior to albendazole based on trials. So single 
dose ivermectin is superior to three doses of albendazole in terms of elimination and 
then getting a second dose of ivermectin two weeks later is marginally better than 
just giving a single dose of ivermectin. That’s for chronic infection, if somebody’s got 
hyperinfection it’s a completely different story. You need to keep treating them until 
they get better and then after that even give them a bit more…in terms of the Australian 
setting, I can’t think of any reason why you wouldn’t give the people ivermectin 
provided they don’t have a particular [no side effects taken with other medications].
Participant 4
The gastrointestinal condition of the person with Strongyloides influences the 
absorption rate of medication at the individual level. Ivermectin is safe and, with the correct 
therapeutic dose, will decrease infection rates:
Both ivermectin and albendazole are not that well absorbed through the gut, so we 
don’t know what therapeutic blood levels are reached in individuals. You’re going to get 
individual variation and variation due to the diet they take and the condition of their 
gut at the time of medication. Given that the medication is relatively safe it’s probably 
still easier to overmedicate someone than to miss the Strongyloides infection.
Participant 5
Policy
The policy theme includes narratives around government funding and institutional racism. 
Control, normalization, and cost influence what illness or disease is declared important 
to public health, which in turn determines funding allocation for control, prevention, and 
drug treatment strategies and initiatives. 
Policy Implications for Controlling Communicable Diseases in Indigenous 
Communities: Case of Strongyloidiasis in Australia
161
Government Funding
Recognizing outbreaks and having the staff to manage them is an issue: 
Certainly, in the [location], we have the Centre for Disease Control, public health 
nurses and doctors that can provide guidance. But often when a community is 
having a big outbreak or a raised prevalence, they say at the Public Health Unit, 
can you [multidiscipline team] come and help us? With the high staff turnover 
in community, certainly not with the health workers, but with the…staff, people 
unless they’ve been around for a long time, they’re nervous about shutting up shop 
for a week, and running around and screening and treating everybody.
Participant 8
Institutional Racism
Avoidance, denial, and normalisation of strongyloidiasis in communities have been de-
scribed as institutional racism by public health and public policy:
Public policy arena there might be some endemic racism, there’s still institutionalised 
racism…I know that the doctors and nurses generally don’t exhibit that. What other 
reason can you come up with for as to why there is such disparity? 
Participant 4
Institutional racism is expressed as a lack of focus on the health of Indigenous people: 
I don’t know it’s one of those things where no one has gone to the trouble of doing 
anything about it for Indigenous people. I suppose it’s one of those institutional 
racism things that health departments can be pretty guilty of.
Participant 6
The government’s normalization and lack of urgency concerning illness affect 
communities with grandparents raising children orphaned by parents succumbing to 
disease (most often considered preventable):
When I first started working in the Department of Health it really annoyed me when 
people would say oh that’s for remote; they can wait as if it wasn’t very important that 
something should happen quickly. I think across the board everyone tends to forget 
that out there is people who are sick, who are very inconvenienced by whatever 
illness it is that they’ve got, and are dying at a very early age which means that you’ve 
got heaps of kids out there without any mothers or fathers. There’s grandmothers 
and aunties who are looking after too many kids for what they deserve because 
they’re looking after all the kids of the ones who’ve died. I don’t know how you do 
it, but there’s definitely this view held by a number of people in the bureaucracy that 
feel that because it’s out bush there’s no real hurry. 
Participant 6
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Further perspectives confirm that there is a lack of urgency concerning to need to 
supply medications to remote areas: 
I suppose in pharmacy is where I first came across [institutional racism]and I’ll 
never forget the first day that I was working in the pharmacy, and a heap of scripts 
came in which is about 500 kilometres away and if you were in a suburban pharmacy 
anywhere and a heap of scripts came in the size of the heap that came in that day 
you’d almost shit yourself. I won’t get these done today. And when I said to the girl 
“wow when do they want these”, she said, “oh it’s all right, there’s no hurry, a couple 
of weeks will do”. That was the first impact that I had of this view that people out 
bush can wait. If a doctor’s seen a patient and want them to have a drug, we make 
sure they get it as quickly as they can in the suburbs but if they live out bush there’s 
nowhere near the same sense of immediacy, and because of that, people are not 
thinking that their medicines are very important.
Participant 6
It is reported that Australia’s Indigenous communities are lacking basic needs and health care: 
It’s a disease considered of a third world country, so it’s not considered a mainstream 
issue, and because the decision makers live in probably first world conditions and 
just doesn’t affect the decision-makers I think that’s the reason that nothing’s done 
or things that can be done aren’t actually addressed, and I think particularly for 
remote Indigenous communities, out of sight is out of mind and that applies to 
other things.
Participant 9
The status of Indigenous communities appears to continue to be deemed lower than 
that of other communities, leading to a lack of urgency in healthcare provision: 
The bureaucracy don’t see it that way but if you see it as institutional racism 
because if it were white people in their own suburbs in mainstream set up, they’d 
be thinking.. better do something about getting rid of it, I suppose the bottom line 
is when something affects you, you’re more likely to want to see something done 
about it…the people that aren’t in influential positions are less likely to have their 
issues addressed than the ones who are in influential positions. 
Participant 9
Learning Opportunity
Combining clinical and community perspectives has the potential to improve health in 
communities, including the eradication and treatment of strongyloidiasis and ongoing 
ethical research. 
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Community Perspective
Community involvement and engagement in all aspects of research are imperative: 
We set an engagement process with community…I think it’s best practice, so it 
shows people, researchers or whoever’s coming in to do this type of work or research 
work, know how to actually engage in a community…we tested the engagement 
process pretty rigorously, and we used it on multiple sites, and we never, ever, ever 
had an issue with engagement on a community with it. 
Participant 1
Non-Indigenous health professionals need exposure and learning opportunities within 
the community for greater awareness and understanding of what is needed:
Because we had non-Indigenous clinicians with us, they just grew from this 
experience; they were just overawed with it. So it was about learning, and also it 
was about them learning of how we operate as well, and what benefits they can get 
from our way of learning and implementing these things, but also incorporating 
their views. Their views were valued too; incorporating their views into our stuff, 
and how we can fit in with that and they can fit in with us. 
Participant 1
……………………
The next step it is really important for us to link with communities and with patients 
and hope that they are willing to let us in. 
Participant 3
Indigenous community Elders play an integral role in the community and need to be 
included:
Aboriginal Elders participating in the discussion and ways of educating community 
leaders…I think their involvement in spreading the information is vital in terms of 
getting control programs going. I think to any success has got to come from them 
and be supported by them. 
Participant 5
There must be ongoing community training within the community to foster a better 
understanding of and engagement with health issues in more acceptable ways:
I’ve found for certain drugs and certain conditions; we don’t always need health 
workers, nurses, doctors, to do stuff.  But if we do want to focus on a particular disease 
or illness, then we actually can train people up with enough information to actually 
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be able to go out and do work in the community - it’s often a lot more acceptable for 
the community workers to go and sit in a home and have a chat about what’s going on 
than to try and drag people to the clinic or for the clinic staff to go out. 
Participant 8
Ethical Research
Research needs to be conducted with the community, not on the community, along with 
appropriate feedback to the community so that appropriate actions can be implemented to 
address the issues:
Our research with community, I got a letter of acknowledgement for the research 
[from] all the traditional owners on that site and from that area, and when the 
research was finished we went around to all those traditional owners and sat 
there and explained what we needed to explain properly,...and they signed the 
acknowledgement that we’d consulted and everything in regards to the completion 
of the research. Now I’ve never, ever seen that data on any research paper that I’ve 
read, I’ve never, ever seen it done…We need to get that message out that people 
need to explain research and what are the benefits of the research for the people 
who are going to be part of the research. 
Participant 1
In working with the community, Indigenous viewpoints must be included in research: 
[An] ethics approval process [must] allow for an Aboriginal viewpoint in regards to 
who we can talk to, who we can’t talk to, who we’re supposed to be talking to, who 




Cost-effective health care in the long term is essential. Appropriate policies for treating and 
preventing Strongyloides must be established, including finding appropriate drug produ-
cers from other companies/countries if necessary. Ivermectin is safe and cost-effective and 
is the best evidence-based treatment:
 [Ivermectin] is not expensive in terms of, in comparison with some other drugs. 
Participant 2
……………………………
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I completely believe in that holistic thing. And, if you can combine a couple of things 
like scabies and Strongyloides, you know how they come together because it was a 
one drug, and you certainly see that with lots of MDAs [Mass Drug Administration]. 
Participant 8
……………………………
You’d probably, in the long run, save a fair bit of money by reducing morbidity for 




There must be a shift from dated clinical perspectives and medical models to a multidisci-
plinary, multifaceted innovation. Knowledge translation as described by the Canadian In-
stitutes of Health Research encompasses an integrated approach and sharing of knowledge 
between researchers and knowledge users (e.g., government, public health, and communi-
ty; CIHR 2016). In this circumstance, knowledge of S. stercoralis (the parasite) and strongy-
loidiasis (the disease) must be shared with all affected communities: 
Information [must] get out to the remote communities [to increase] their level of 
knowledge and understanding of this infection. 
Participant 5
……………………….
I think in a first world country like Australia; we should be able to expect that a 
condition that is an infectious chronic disease that’s transmissible through poor 
sanitation should be something that is notifiable and then you have appropriate 
public health strategies to address it. 
Participant 9
Knowledge translation among health professionals and communities increases 
education about S. stercoralis, which is crucial for treating and preventing strongyloidiasis: 
You need education for GPs, the health professionals. You need education for the 
community, and then the next group will be that environmental health group that 




Community-based partnerships along with community acknowledgement and respect for 
community/traditional owners are essential components of any intervention. 
Identification
Intervention begins at the identification of each community: 
Identifying the communities that are affected…my thinking has been that the ones 
that are most neglected are the ones that are then going to be identified.
Participant 9
We need to acknowledge that the community’s need of a particular level of health 
service is as important as the needs of urban areas:
In the infrastructure of the way primary health care is delivered to people, you’ve 
got to make sure that your systems are in place to ensure that people out bush get as 
close as possible to the same level of service as people in the suburbs in mainstream.
Participant 6
We need to move away from treating on an individual case-by-case basis toward a 
community-level approach and intervention: 
I think it requires a massive undertaking from community members as well as 
from the treating health centres to actually make that happen. Policy-wise, for 
Strongyloides, I’m still a little bit out on that. At the moment we treat individuals. 
And I haven’t done enough analysis yet to see how much of that is household 
clustering. At the moment, policy-wise for Strongyloides, we just treat the person. 
We don’t even screen the rest of the household.
Participant 8
Working with the community to identify their specific circumstances and needs in 
order to plan strategies and outcomes is important: 
Each community is unique, as you know, and each community gazes in different 
ways, and we’ve got to work out and do the homework on how which engagement 
process will work to get the maximum benefit. You’re looking at a multifaceted 
approach in regards to the engagement process.
Participant 1
Health promotion and prevention programs/strategies
Health education and promotion are ways to involve the community in eradicating stron-
gyloidiasis. Engaging children about the benefits to their health and well-being of under-
standing the parasite is a key message:
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Kids were integral to that little project and yeah, frigging fantastic. We followed 
up on it too, with health education and health promotion, and we integrated the 
regular worming cycles and that with the child health checks. Everyone’s happy 
there, no one’s got worms, they’re going to school, the houses are clean. 
Participant 1
Community engagement activities need to include adults and children:
Would be good if you got the adults educating the kids, so you teach the adults and 
the community health workers or whatever or other adults. Then the parents would 
know that too to be more careful of it because you’re teaching the kids so it would 
stick in their mind a bit more too.
Participant 4
With support, community representation can enhance diagnosis and treatment strategies: 
There has been some attempt in educating people in remote communities in regards 
to this infection, and once they are convinced of this worm and the presence of 
this worm, usually they’re quite supportive in the program. Whether or not the 
government authorities will support and fund the diagnosis and treatment of this 
infection. I think it varies. The more community voices that speak up in regards 
to removing Strongyloides from their communities the more effective it would be.
Participant 5
Strategies need to focus on concurrent infections and conditions: 
Mass treatment’s the go because you’re not only looking at treating for Strongyloides 
if you give someone ivermectin you’re looking at all the other parasites and things you 
can kill as well. And these people should be thinking outside of the square because 
most of the people on the community and the kids are, they’re polyparasitised, so 
they’ve got multiple parasitic infections, not just Strongyloides. If we’re going to 
treat, we’re going to knock on the head all these other things that are impacting on 
people’s lives as well.
Participant 1
Kids should be mass-treated for all worms: 
You’ve got the potential to [do] the de-worming for all the kids, to be able to have 
kids de-wormed.  We don’t test the kids because we don’t do blood on kids but the 
kids could be de-wormed with ivermectin and albendazole  and then the adults 
at the time you’re doing the blood…and then you follow them up if they’ve got a 
positive result and then you’ve got the education
Participant 6
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Treatment programs must include the people and their environment. Public health 
approaches with standard guidelines continue to be required, but innovative strategies 
must be incorporated to be flexible and fluid at the community level in order to treat and 
decrease Strongyloides: 
Existing policies and guidelines, however, if you’re looking at it from a clinical 
perspective it’s very narrow, like the CARPA manual (CARPA 2014), it’s quite anal, we 
look at it and think, “Oh yeah, just chuck a pill down someone’s head, and that’s all.”  
Well, that’s not how it’s going to work. By having those policies and procedures, they 
need to be innovative and open enough to be able to do innovative work and not rigid.
Participant 1
A main element of any treatment protocol must be the environment: 
It’s very simple; it comes down to nineteen-century public health measures. If you can 
bring in the nineteenth-century public health measures…you do a bit of treatment, 
whether it’s selective mass treatment or mass treatment or just individuals when 
they come in sick, and that’s enough awareness of it to consider strongyloidiasis, 
it doesn’t really matter. But it just comes down to basic sort of bread and butter 
sanitation issues I reckon.
Participant 4
……………………
The issue is whether or not you do a mass treatment program and I think that if you 
do a mass treatment program without having improved sanitation you’re actually 
wasting your time to a degree. That said, you can’t write these things off, but the 
sanitation is what keeps it going.
Participant 4
Eradication via routine drug administration could be an accepted protocol in 
community treatment programs: 
For Strongyloides control…a once-yearly mass drug administration can drop the 
prevalence of Strongyloides very quickly.
Participant 8
The routine screening and treatment of many people increase the accuracy of prevalence 
rate measurement: 
It would be good if done as a routine and would also give you more of an idea of the 
prevalence. But obviously there’s a selection bias because it’s only people presenting 
with diarrhoea, but it’s a start. It’s also a marker for programs designed…in terms 
of eradication so if you were going to do selective mass treatment you need to have 
some sort of marker as to an outcome or improve sanitation.
Participant 4
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Developing innovative technologies may increase testing success:
Unfortunately, we don’t have any point of care test which would be useful. I think 
what is needed is some testing system that can be done with low technology so 
that we don’t rely on collecting the specimen and sending it into a major centre for 
testing, [so] it can be done out in a field laboratory type environment.
Participant 5
Registration/Prevalence
Gaining a better understanding of Strongyloides and of the full extent of the prevalence of the 
parasite requires that a national registry be created. Monitoring S. Stercoralis is necessary for an 
effective and long-term intervention. Our understanding of infection, transmission, and preva-
lence can be improved through registration similar to that used for other diseases like scabies:
There have been suggested approaches to having a Strongyloides register so that 
we can tell which individuals are infected or have been infected and it remains on 
their record so that if further down the track treatment has been effective then the 
Dr. can re-treat that individual. In terms of spread of this infection if you have a 
register, you can see or track where it’s likely to, spread, to occur.
Participant 5
By monitoring the details of infection, protocols can be developed to address the 
particular circumstances/situations associated with infection: 
The first thing I’d do is make strongyloidiasis notifiable, so you could actually gather 
your data for who was positive and then do some mapping…a register to gather all 
of that information to answer some of the questions for a disease that hasn’t had 
much research go into it, and then you’ve got the general practice primary health 
care setting, and that can have a protocol for people coming through.
Participant 9
……………………….
The information and the access to data and the clarification of data coming out…
doesn’t acknowledge the incidence of Strongyloides.
Participant 1
Discussion
This study presents perspectives from experienced health professionals and researchers 
working directly with Australian Indigenous communities who treat and diagnose infec-
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tious diseases, specifically strongyloidiasis. The overall themes presented were barriers to 
health/treatment, prevention, access to health care, policy implications, learning opportu-
nities, and ideas for intervention. 
Barriers to Health and Treatment
The key themes for S. stercoralis infection and subsequent acute and chronic disease includ-
ed racism, diagnosis/clinical knowledge, and community in context. As shown in Miller et 
al. (2014), racial disparity and living conditions comprise the situational context influenc-
ing the key barriers. Continued unsanitary living conditions in communities increases S. 
stercoralis exposure. Environmental health policy is necessary for effecting changes in hous-
ing infrastructures, functioning plumbing, and enhanced sanitary hygiene and toileting in 
communities. S. stercoralis thrives in unsanitary communal areas (e.g., flooring in housing 
and outdoor leaking plumbing with exposure to faeces are active agents for strongyloidia-
sis infection and transfer). S. Stercoralis is diagnosed more frequently in rural and remote 
communities and is often associated with limited access to toilets or non-functioning sew-
age facilities (Kaminsky, Reyes-Garcia and Zambrano 2016). Concerning racial disparities, 
racism is perceived by participants in the lack or absence of public policy addressing envi-
ronmental health issues and funding designed to make changes in affected communities. 
Diagnosis and Treatment
Diagnosis continues to be difficult, as Strongyloides has a wide range of symptoms and op-
posing situations of asymptomology. Hyperinfection, HIV/AIDS, chronic alcoholism, ma-
lignancy, tuberculosis, chronic malnutrition, chronic renal failure, and exposure in endemic 
countries are all found to be factors associated with strongyloidiasis (Kaminsky, Reyes-Garcia 
and Zambrano 2016). Diarrhea is a significant symptom across patients with strongyloidiasis 
diagnosis. Strongyloidiasis often appears asymptomatic as presented in a six-year-old child 
(no abdominal pain, diarrhea, cough, urticarial or pruritus, wheezing, or skin abnormality) 
and in a survey of stool samples of children in Viti Levu Fiji (Kim et al. 2016; Zubrick et al. 
2004). One case presenting at hospital with one week of abdominal pain and distention and 
vomiting was determined to be hyperinfection symptoms, later including a necrotic jejunal 
area and respiratory failure. The individual was treated with ivermectin, albendazole, and a 
broad-spectrum antibiotic. Unfortunately, mortality occurred after 32 days of hospitalization 
(Figueira et al. 2015). High-risk patients (such as those with the factors above) require man-
datory screening prior to steroid treatment for quick and efficient diagnosis and treatment 
and to clear infection and avoid the hyperinfection and dissemination that can result from 
prolonged diagnosis (Kaminsky, Reyes-Garcia and Zambrano 2016). 
The lack of knowledge among practitioners and community members of S. stercoralis 
and its required treatment strongly indicates the continued need for research, awareness, 
and policy changes. The findings of this research indicate  a notable lack of knowledge 
about strongyloidiasis. Kaminsky, Reyes-Garcia, and Zambrano (2016) described issues in 
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Honduras similar to those Miller et al. (2014) described in Australia, including a failure to 
recognize symptoms, an inadequate knowledge of treatment protocol, and a lack of interest 
in defining and raising awareness of S. stercoralis infection in the community. 
Access to Health Care
The 2014 Aboriginal and Torres Strait Islander Health Performance Framework Report 
(AIHW 2015) supports the perspectives of the participants interviewed for this study. Data 
on infectious and parasitic diseases (2008–2012 data) report that mortality rates per 100,000 
were higher for those identified as Indigenous (19.4) than for those identified as Non-Indige-
nous (9.2). In addition, 29.9% of those identified as Indigenous aged 15 years or older report-
ed problems accessing services, with 42.0 % located in remote areas and 25.9% in non-remote 
areas (2008 data). The Health Performance Framework Report (AIHW 2015) reported that 
the barriers to accessing health care services for remote areas were as follows: “no services in 
area” (23.7%), “not enough services in area” (20.5%), “waiting time too long or not available 
at time needed” (15.9%), “services not culturally appropriate” (2.5%), “don’t trust services” 
(3.3%), and “treated badly/discriminated against” (1.4%).
Policy
The perspectives about institutional racism and normalisation reported by the health care 
professionals in this study present a strong message for policy analysts and developers. In-
stitutional racism refers to the ways in which beliefs and values have been built into insti-
tutional operations (e.g., social, health) in a way that discriminates against, controls, and 
oppresses groups (McConnachie, Hollingsworth and Pettman 1988; Henry, Houston and 
Mooney 2004). Henry et al. (2004) state that institutional racism can be covert, unrecog-
nized, or unacknowledged by those in the institutions. They outline particular examples in 
Australian health care, including (1) funding inequality, (2) different performance criteria 
for black and white, (3) “body part” funding, (4) differences in treatment regimes, (5) in-
equitable Medicare Primary Health Care (Medicare Benefits Schedule plus Pharmaceuti-
cal benefits scheme), and (6) cultural barriers to the Indigenous use of healthcare services 
(Henry et al. 2004). 
The Commonwealth Department of Health and Aging (2001) reported some of the same 
barriers to access in Indigenous health, including poor, unwelcoming interaction within 
private, government, and specialist sectors of health services. The National Aboriginal and 
Torres Strait Islander Health Council (NATSIHC 2003) report lower use/access to health 
services despite decreased health status and increased health care needs. They point out 
the need to prioritise allied health care, aged care, and acute care in Indigenous health. In 
2002, the National Health and Medical Research Council (NHMRC) suggested areas for 
reform in Indigenous health and reported specific issues described as barriers to health 
system access, such as living with racism and poverty. The NHMRC (2002) proclaims that 
health services delivery is determined as a risk resulting from low levels of trust in health 
care and a need to understand what effective, accessible health services are and the reasons 
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why services fail. Further, the focus needs to be on equality in health care and improving 
health systems and cultural safety. 
Although efforts toward policy changes for Indigenous health have been made in 
Australia, there continues to be a disparity in health and social outcomes (Anderson et 
al. 2006). Gaps continue to exist in local/regional health information systems in terms of 
both development and feedback, as well as a lack of Indigenous contribution to health 
frameworks and indicators for supporting Indigenous health (Smylie et al. 2006). Similarly, 
Tang and Browne (2008) argued that race and racialisation exist within the Canadian 
health care system, that health care is not free from discrimination, and thus that issues 
with socioeconomic contexts result in inequitable access to health care. Hole et al. (2015) 
suggest that dealing with issues of visibility and voice to foster cultural safety and reporting 
health care quality improvements such as practice, policy and environmental strategies 
are needed. In 2010, the NHMRC re-evaluated the continued disparity in the health and 
social outcome statuses of Indigenous health in Australia and streamlined and redefined 
the suggested priorities and objectives. The objectives shifted to (1) promoting knowledge 
transfer at the community level to provide input to service planning; (2) identifying health 
infrastructure requirements; (3) evaluating increases and risk factors in chronic conditions, 
and (4) evaluating models of care (NHMRC 2010). 
Learning Opportunity
 Developing practices in collaboration between health authorities, health professionals, and 
communities is essential (Hole et al. 2015). Coordination and planning that includes com-
munity perspectives and engagement and public health approaches (Einseidel and Wood-
man 2010; Shield and Page 2008; Miller et al. 2014) will improve health outcomes. 
Ideas for Intervention
 The data analysis in this study defined cost, knowledge translation, community partner-
ships, and registration/prevalence as key factors for strategizing interventions. These factors 
combined would increase intervention successes. Affordable drug costs, permitted by the 
Australian drug scheme (PBS), would increase access to ivermectin (NPS Medicinewise 
2014; NPS Medicinewise 2015), the most effective treatment for strongyloidiasis. Knowl-
edge translation requires active collaboration with communities, public health organisa-
tions/agencies, and researchers at all steps in the process—from identification, through 
procedure and research, and finally to intervention strategies—along with continual feed-
back for all partners is an elaborate strategy defined and supported by the Canadian In-
stitutes of Health Research (CIHR 2016).  To ensure knowledge translation, community 
partnerships must be developed by identifying each community and their context to ensure 
the full development of community engagement, recognition, and inclusion by all those in 
the partnership.  
Registration and tracking the prevalence rates of S. stercoralis and strongyloidiasis can 
establish numbers for policy development and assist in the development of intervention 
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strategies by the community, public health organisations/agencies, and researchers. These 
factors, either separately or, preferably, as a combined strategy, are significant for policy. 
Public health policy that develops interventions and guidelines for diagnosis and treatments 
are essential (Miller et al. 2014; Adam, Page and Speare 2003; Soulsby, Hewagama and 
Brady 2012; Speare and White 2001; Shield and Page 2008). 
Implications
This study offers direct policy implications for Indigenous communities. The need for policy 
development aimed at the prevention of neglected tropical diseases in Indigenous commun-
ities is highlighted. Increased knowledge and understanding of treatment, diagnosis, and 
healthcare access concerning S. stercoralis among health professionals and policymakers 
are necessary components of positive outcomes for Indigenous health. Raising awareness 
of systemic institutional racism in the control and prevention of neglected tropical diseases 
in Indigenous communities is required for effective and sustainable change. A health pro-
motion framework can provide the basis for multiple levels of intervention to control and 
prevent Strongyloides in Indigenous communities.
Limitations
Few health professionals in Australia have extensive knowledge of the S. stercoralis parasite, 
infection, diagnosis, and treatment or experience with Indigenous communities. The au-
thors interviewed many of these professionals and reached saturation but acknowledge that 
the sample was limited. 
Conclusions
This study highlights the importance of the evidence-based reporting and declaration of 
strongyloidiasis as a notifiable disease (Speare, Miller and Page 2015). Barriers to controlling 
strongyloidiasis have been identified in this study, in line with previous research (Miller et al. 
2014; Speare and White 2001; Page and Shield 2005; Kaminsky, Reyes-Garcia and Zambrano 
2016). In-depth interviews with health service providers active in the field support this evi-
dence. Raising awareness of institutional racism within the health care system, as described by 
the health professionals in this study, can contribute to policy change. The health care system 
cannot adequately address the barriers to prevention, treatment, and control until this institu-
tional racism is brought to the forefront of policy development and change. 
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